BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35787163)

  • 1. Immobilisation hypercalcaemia.
    Mifsud S; Mifsud EL; Agius SM; Mula A; Gruppetta M
    Br J Hosp Med (Lond); 2022 Jun; 83(6):1-7. PubMed ID: 35787163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of early diagnosis of cancer-related hypercalcaemia].
    Radványi I; Csikós A; Balogh S
    Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme hypercalcaemia caused by immobilisation due to acute spinal cord injury.
    Tettero JM; van Eeghen E; Kooter AJ
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34083190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate.
    Selby PL; Davies M; Marks JS; Mawer EB
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):531-6. PubMed ID: 8548936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of cancer associated hypercalcaemia.
    Ralston SH
    Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to approach hypercalcaemia.
    Crowley R; Gittoes N
    Clin Med (Lond); 2013 Jun; 13(3):287-90. PubMed ID: 23760705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the Child with Hypercalcaemia.
    Davies JH
    Endocr Dev; 2015; 28():101-118. PubMed ID: 26138838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypercalcaemia of malignancy in adults.
    Mc Donald D; Drake MT; Crowley RK
    Clin Med (Lond); 2023 Sep; 23(5):503-507. PubMed ID: 37775175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcaemia in association with renal failure: the role of immobilisation.
    Prince RL; Eisman JA; Simpson RW
    Aust N Z J Med; 1983 Feb; 13(1):8-10. PubMed ID: 6576751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and management of hypercalcaemia.
    Koh LK
    Ann Acad Med Singap; 2003 Jan; 32(1):129-39. PubMed ID: 12625112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral hypercalcaemia of malignancy associated with a gigantic cutaneous squamous cell carcinoma.
    Elantably D; Al Armashi AR; Hammad F; Alkrekshi A
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36323452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of hypercalcaemia.
    Ralston SH
    Br J Clin Pharmacol; 1992 Jul; 34(1):11-20. PubMed ID: 1633063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcaemia in primary oxalosis: role of increased bone resorption and effects of treatment with pamidronate.
    Yamaguchi K; Grant J; Noble-Jamieson G; Jamieson N; Barnes ND; Compston JE
    Bone; 1995 Jan; 16(1):61-7. PubMed ID: 7742085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immobilisation hypercalcaemia. 1 case (author's transl)].
    Baglin A; Goupil A; Lortat-Jacob A; Arfi S; Gueris J; Milhaud G; Benoit J
    Nouv Presse Med; 1978 Feb; 7(6):453-5. PubMed ID: 634783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders.
    Sargent JT; Smith OP
    Br J Haematol; 2010 May; 149(4):465-77. PubMed ID: 20377591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypercalcaemia].
    Andersen TS; Vestergaard P
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis and management of hypercalcaemia.
    Minisola S; Pepe J; Piemonte S; Cipriani C
    BMJ; 2015 Jun; 350():h2723. PubMed ID: 26037642
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical perspective of parathyroid hormone related hypercalcaemia.
    Han CH; Fry CH; Sharma P; Han TS
    Rev Endocr Metab Disord; 2020 Mar; 21(1):77-88. PubMed ID: 31797261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of malignant hypercalcaemia.
    Stevenson JC
    Drugs; 1988 Aug; 36(2):229-38. PubMed ID: 3053127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
    Coukell AJ; Markham A
    Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.